Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial

Tamiru Shibiru Degaga, Geremew Gashaw Gessa, Rupam Tripura et al.|The Lancet Infectious Diseases|2026

Cited by 8